Wed, March 7, 2012
Tue, March 6, 2012
[ Tue, Mar 06th 2012 ] - Market Wire
Verotoxin and E. coli 0157
Mon, March 5, 2012
[ Mon, Mar 05th 2012 ] - Market Wire
Sienna Gold Warrants Extended
[ Mon, Mar 05th 2012 ] - Market Wire
30 a.m. ET
Fri, March 2, 2012
Thu, March 1, 2012
Wed, February 29, 2012
Tue, February 28, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
Alere to Acquire eScreen, Inc.
[ Tue, Feb 28th 2012 ] - Market Wire
ICON Acquires PriceSpective
Mon, February 27, 2012
Sat, February 25, 2012
Fri, February 24, 2012
[ Fri, Feb 24th 2012 ] - Market Wire
BrainStorm Featured on CNBC
Thu, February 23, 2012

Idenix Pharmaceuticals to Present at Three Upcoming Investor Conferences


//health-fitness.news-articles.net/content/2012/ .. sent-at-three-upcoming-investor-conferences.html
Published in Health and Fitness on Wednesday, February 29th 2012 at 13:22 GMT by Market Wire   Print publication without navigation


Idenix Pharmaceuticals to Present at Three Upcoming Investor Conferences -- CAMBRIDGE, Mass., Feb. 29, 2012 /PRNewswire/ --

Idenix Pharmaceuticals to Present at Three Upcoming Investor Conferences

[ ]

CAMBRIDGE, Mass., Feb. 29, 2012 /PRNewswire/ -- Idenix Pharmaceuticals, Inc., (NASDAQ: [ IDIX ]) announced today that Idenix management will present a corporate overview at the Cowen and Company 32nd Annual Healthcare Conference on March 7, 2012 at 8:40 a.m. ET at the Boston Marriott Copley Place, Massachusetts; the 24th Annual Roth Conference on March 12, 2012 at 4:00 p.m. PT at the Ritz Carlton Laguna Niguel, California; and the Barclays Capital Global Healthcare Conference on March 14, 2012 at 2:30 p.m. ET at the Loews Miami Hotel, Florida.

The live and archived webcasts of the company presentations can be accessed under "Calendar of Events" in the Idenix Investor Center at [ www.idenix.com ]. Please log in approximately 5-10 minutes before each event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conferences.

About Idenix

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to [ http://www.idenix.com ].

Idenix Pharmaceuticals Contacts:
Kelly Barry (617) 995-9033 (media)
Teri Dahlman (617) 995-9807 (investors)

SOURCE Idenix Pharmaceuticals, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.idenix.com ]


Publication Contributing Sources